Interestingly, it has been shown that FGF15/19 and FGF21 have potential roles in metabolic diseases, such as nonalcoholic fatty liver disease, bile acid diarrhea, cardiovascular disease and diabetes. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.